MoneyWorks4Me

Norris Medicines informs about outcome of board meeting

13 Feb 2023 Evaluate
Norris Medicines has informed that the Board of Directors at their Meeting held on 13th February, 2023, has approved the Unaudited financial results for the Quarter and nine months ended 31st December 2022. As per Regulation 33 of Listing Regulations, the Financial Results and Limited Review Report are enclosed for records. The Meeting of the Board of Directors concluded at 12:30 PM.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1736.70
Dr. Reddys Labs. 1241.45
Cipla 1318.20
Lupin 1943.20
Zydus Lifesciences 1113.95
View more..